Osborne Partners Capital Management LLC boosted its stake in Stericycle, Inc. (NASDAQ:SRCL) by 5.5% during the second quarter, Holdings Channel reports. The fund owned 82,709 shares of the business services provider’s stock after buying an additional 4,345 shares during the period. Osborne Partners Capital Management LLC’s holdings in Stericycle were worth $6,312,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of SRCL. Kernodle & Katon Asset Management Group LLC purchased a new position in Stericycle during the first quarter valued at approximately $100,000. Heritage Trust Co purchased a new position in Stericycle during the first quarter valued at approximately $124,000. Pacer Advisors Inc. raised its position in Stericycle by 3.3% in the first quarter. Pacer Advisors Inc. now owns 1,735 shares of the business services provider’s stock valued at $144,000 after buying an additional 55 shares during the last quarter. Invictus RG purchased a new position in Stericycle during the first quarter valued at approximately $145,000. Finally, Morgan Dempsey Capital Management LLC raised its position in Stericycle by 2.6% in the first quarter. Morgan Dempsey Capital Management LLC now owns 1,902 shares of the business services provider’s stock valued at $158,000 after buying an additional 48 shares during the last quarter. 95.49% of the stock is owned by institutional investors.

Stericycle, Inc. (SRCL) traded up 0.72% during mid-day trading on Tuesday, reaching $76.96. 123,883 shares of the company were exchanged. Stericycle, Inc. has a 1-year low of $71.52 and a 1-year high of $107.74. The stock has a market capitalization of $6.56 billion, a price-to-earnings ratio of 40.10 and a beta of 0.14. The stock’s 50-day moving average price is $77.34 and its 200-day moving average price is $80.78.

Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, May 4th. The business services provider reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. Stericycle had a return on equity of 14.40% and a net margin of 5.23%. The company had revenue of $892.40 million during the quarter, compared to analysts’ expectations of $874.34 million. During the same period last year, the business posted $1.11 EPS. Stericycle’s revenue for the quarter was up 2.1% on a year-over-year basis. On average, equities research analysts anticipate that Stericycle, Inc. will post $4.62 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This news story was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/07/25/stericycle-inc-nasdaqsrcl-stake-raised-by-osborne-partners-capital-management-llc.html.

Several research analysts have commented on SRCL shares. Jefferies Group LLC reaffirmed a “buy” rating and set a $108.00 price objective on shares of Stericycle in a research note on Thursday, July 13th. Zacks Investment Research raised shares of Stericycle from a “hold” rating to a “buy” rating and set a $85.00 target price for the company in a research note on Wednesday, July 5th. Deutsche Bank AG lowered their target price on shares of Stericycle from $14.00 to $10.00 and set a “buy” rating for the company in a research note on Monday, May 15th. BMO Capital Markets initiated coverage on shares of Stericycle in a research note on Thursday, June 29th. They set a “market perform” rating and a $81.00 target price for the company. Finally, Barclays PLC initiated coverage on shares of Stericycle in a research note on Thursday, April 13th. They set an “overweight” rating and a $100.00 target price for the company. Four analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $81.15.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle, Inc. (NASDAQ:SRCL).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.